Mounjaro is now a heavyweight in weight-loss fight

Mounjaro, a weight-loss drug by Eli Lilly, saw a huge jump in sales after its India launch. Sales of Mounjaro injections increased significantly in April. Doctors are observing its effectiveness and side effects on Indian patients. Obesity is prevalent in India. Affordability and tolerance are key factors. Studies suggest constipation is a common side effect.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/PbVD0QM
via IFTTT